Short Interest in Quantum-Si incorporated (NASDAQ:QSIAW) Decreases By 26.7%

Quantum-Si incorporated (NASDAQ:QSIAW) was the target of a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 3,340 shares, a decline of 26.7% from the November 30th total of 4,556 shares. Based on an average daily volume of 11,439 shares, the short-interest ratio is presently 0.3 days. Based on an average daily volume of 11,439 shares, the short-interest ratio is presently 0.3 days.

Quantum-Si Stock Down 20.7%

Quantum-Si stock traded down $0.05 during trading hours on Tuesday, reaching $0.19. 60,230 shares of the stock were exchanged, compared to its average volume of 52,335. Quantum-Si has a 52-week low of $0.11 and a 52-week high of $2.23. The firm’s 50 day moving average is $0.31 and its 200 day moving average is $0.41.

Quantum-Si Company Profile

Quantum-Si, Inc (NASDAQ: QSIAW) is a life sciences company focused on developing a next-generation protein sequencing platform. The company aims to unlock the proteome by enabling single-molecule protein analysis, a capability that promises to advance drug discovery, diagnostic development and molecular biology research. Quantum-Si’s core technology leverages proprietary semiconductor-based nanopore arrays and optical detection to directly sequence proteins and quantify expression patterns with high sensitivity.

Headquartered in Pleasanton, California, Quantum-Si was founded to address limitations in existing proteomics methods, such as mass spectrometry, which can be time-consuming and less sensitive to low-abundance proteins.